Systemic hemodynamic, neurohormonal, and renal effects of a steady-state infusion of human brain natriuretic peptide in patients with hemodynamically decompensated heart failure
- 1 March 1998
- journal article
- clinical trial
- Published by Elsevier in Journal of Cardiac Failure
- Vol. 4 (1) , 37-44
- https://doi.org/10.1016/s1071-9164(98)90506-1
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Atrial natriuretic factor: Its (patho)physiological significance in humansKidney International, 1992
- Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.Journal of Clinical Investigation, 1991
- Tolerance to intravenous nitroglycerin in patients with congestive heart failure: Role of increased intravascular volume, neurohumoral activation and lack of prevention with N-acetylcysteineJournal of the American College of Cardiology, 1990
- Vasodilatory action of endogenous atrial natriuretic factor in a rat model of chronic heart failure as determined by monoclonal ANF antibody.Circulation Research, 1990
- Prevention and Reversal of Nitrate Tolerance in Patients with Congestive Heart FailureNew England Journal of Medicine, 1987
- Arrhythmias Associated with Intermittent Outpatient Dobutamine InfusionAngiology, 1986
- Clinical Effects and Side Effects of AmrinoneArchives of internal medicine (1960), 1985
- Tolerance to dobutamine after a 72 hour continuous infusionThe American Journal of Medicine, 1980
- The toxicity of sodium nitroprussideCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1976
- Sodium NitroprussideAnesthesiology, 1976